J Eduardo Sousa

Summary

Country: Brazil

Publications

  1. ncbi request reprint Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system. Initial experience in Latin America
    Juan Simon Muñoz
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 83:63-8; 57-62. 2004
  2. doi request reprint Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system
    J Ribamar Costa
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    JACC Cardiovasc Interv 1:545-51. 2008
  3. ncbi request reprint Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up
    J E Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 104:2007-11. 2001
  4. ncbi request reprint Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 110:e5-6. 2004
  5. ncbi request reprint Are paclitaxel-eluting stents safe and effective in patients with acute coronary syndromes?
    J Eduardo Sousa
    Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil
    Nat Clin Pract Cardiovasc Med 2:566-7. 2005
  6. ncbi request reprint New frontiers in cardiology: drug-eluting stents: Part II
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Av Dr Dante Pazzanese, 500 Ibirapuera, 04012180, Sao Paulo, Brazil
    Circulation 107:2383-9. 2003
  7. ncbi request reprint New frontiers in cardiology: drug-eluting stents: Part I
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 107:2274-9. 2003
  8. ncbi request reprint New frontiers in interventional cardiology
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 111:671-81. 2005
  9. ncbi request reprint Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 107:24-7. 2003
  10. ncbi request reprint Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis
    Fausto Feres
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Am J Cardiol 96:1656-62. 2005

Collaborators

Detail Information

Publications59

  1. ncbi request reprint Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system. Initial experience in Latin America
    Juan Simon Muñoz
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 83:63-8; 57-62. 2004
    ..To assess the safety and efficacy of intracoronary brachytherapy using the Beta-Cath system for preventing recurrence of in-stent restenosis (ISR), by analyzing clinical, angiographic, and intracoronary ultrasound (ICUS) results...
  2. doi request reprint Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system
    J Ribamar Costa
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    JACC Cardiovasc Interv 1:545-51. 2008
    ..We sought to investigate the performance and efficacy of the third-generation polymer-free Vestasync-eluting stent (VES)...
  3. ncbi request reprint Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up
    J E Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 104:2007-11. 2001
    ..The aim of the present investigation was to determine whether these results are sustained over a period of 1 year...
  4. ncbi request reprint Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 110:e5-6. 2004
  5. ncbi request reprint Are paclitaxel-eluting stents safe and effective in patients with acute coronary syndromes?
    J Eduardo Sousa
    Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil
    Nat Clin Pract Cardiovasc Med 2:566-7. 2005
  6. ncbi request reprint New frontiers in cardiology: drug-eluting stents: Part II
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Av Dr Dante Pazzanese, 500 Ibirapuera, 04012180, Sao Paulo, Brazil
    Circulation 107:2383-9. 2003
  7. ncbi request reprint New frontiers in cardiology: drug-eluting stents: Part I
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 107:2274-9. 2003
  8. ncbi request reprint New frontiers in interventional cardiology
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 111:671-81. 2005
  9. ncbi request reprint Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 107:24-7. 2003
    ..We have previously reported the safety and effectiveness of sirolimus-eluting stents for the treatment of de novo coronary lesions. The present investigation explored the potential of this technology to treat in-stent restenosis...
  10. ncbi request reprint Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis
    Fausto Feres
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Am J Cardiol 96:1656-62. 2005
    ..In conclusion SES implantation for the treatment of ISR was effective and superior to catheter-based IVBT in preventing recurrent neointimal proliferation and angiographic restenosis at 1-year follow-up...
  11. doi request reprint Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry
    J Ribamar Costa
    Instituto de Ensino e Pesquisa, Hospital do Coração, Sao Paulo, Brazil
    JACC Cardiovasc Interv 3:12-8. 2010
    ..Our aim was to access the incidence of late major adverse cardiac events (MACE) and stent thrombosis (ST) in nonselected, complex patients followed for a period >/=4 years...
  12. doi request reprint One-year results of the INSPIRE trial with the novel MGuard stent: serial analysis with QCA and IVUS
    J Ribamar Costa
    Department of Invasive Cardiology, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 78:1095-100. 2011
    ..Although the acute results (<30 days) have pointed to the efficacy of this novel device, few is known about its long-term performance...
  13. doi request reprint Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization
    Felipe Maia
    Instituto Dante Pazzanese de Cardiologia, Av Dr Dante Pazzanese 500, Ibirapuera, CEP, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 76:86-92. 2010
    ..To assess the efficacy of the MGuard(TM) stent combining a polymer-mesh sleeve attached to the external surface of a bare-metal stent in preventing distal embolization during percutaneous coronary intervention (PCI)...
  14. ncbi request reprint Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilation
    Juan S Munoz
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Am J Cardiol 93:1522-5. 2004
    ..At 6-month follow-up, similar in-stent late luminal loss and decreased neointimal hyperplasia volume were seen in the 2 groups, preserving the luminal dimensions at the edges of the stents...
  15. ncbi request reprint Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 111:2326-9. 2005
    ..Our goal was to evaluate the clinical, angiographic, and intravascular ultrasound (IVUS) outcomes of patients treated with SESs 4 years after implantation...
  16. doi request reprint 1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial
    J Ribamar Costa
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    JACC Cardiovasc Interv 2:422-7. 2009
    ....
  17. ncbi request reprint Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: a serial intravascular ultrasound study
    Aurea J Chaves
    Invasive Cardiology Section, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 66:535-40. 2005
    ..Considering the efficacy/safety balance, our results do not encourage further trials evaluating the current protocol for the prevention of in-stent restenosis...
  18. ncbi request reprint Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent
    Alexandre Abizaid
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Am J Cardiol 99:1403-8. 2007
    ..The inhibition of neointima formation as measured by follow-up angiography and IVUS after 4 months suggests therapeutic potential for the reduction of restenosis...
  19. ncbi request reprint A novel mechanism explaining early lumen loss following balloon angioplasty for the treatment of in-stent restenosis
    Mariano Albertal
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Am J Cardiol 95:751-4. 2005
    ..These results on intravascular ultrasound suggest compression and decompression as the main mechanisms for early lumen loss after dilatation of in-stent restenotic lesions...
  20. ncbi request reprint Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial
    Aurea J Chaves
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Circulation 109:861-6. 2004
    ..Whether this is a result of a lower restenosis rate caused by inhibition of intimal hyperplasia remains to be defined...
  21. ncbi request reprint Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents
    Juan S Munoz
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Am J Cardiol 93:470-3. 2004
    ..At 1-year follow-up, there were no significant quantitative changes in intravascular ultrasound measurements within the overlapped segment...
  22. doi request reprint Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late "catch-up" phenomenon after Cypher® sirolimus-eluting stent implantation
    Daniel Chamié
    Instituto Dante Pazzanese de Cardiologia, Av Dr Dante Pazzanese, 500, Ibirapuera, 04012 180, Sao Paulo, SP, Brazil
    Int J Cardiovasc Imaging 27:867-74. 2011
    ..In the non-complex scenario, SES implantation was associated with a minimal, non-significant increase in the IH volume between 8 and 20 months...
  23. ncbi request reprint EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions
    J Ribamar Costa
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    EuroIntervention 4:53-8. 2008
    ..140 microg of sirolimus) and therefore has a lower polymer load. We sought to evaluate the safety and efficacy of this novel device in reducing neointimal hyperplasia as assessed by QCA and IVUS...
  24. ncbi request reprint First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial
    Alexandre Abizaid
    Institute Dante Pazzanese of Cardiology, Av Dr Dante Pazzanese 500, Ibirapuera, Sao Paulo, SP, Brazil
    J Am Coll Cardiol 43:1118-21. 2004
    ..The purpose of the study was to examine the safety and efficacy of 17-beta-estradiol-eluting stent implantation on coronary de novo lesions...
  25. ncbi request reprint Late vascular response at the edges of sirolimus analogous-eluting stents in diabetic patients: An intravascular ultrasound study
    Leandro I Lasave
    Interventional Cardiology Section, Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 70:498-503. 2007
    ..Recently, Biolimus and Zotarolimus have demonstrated potent antiproliferative effects...
  26. ncbi request reprint Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial
    Alexandre Abizaid
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 70:654-60. 2007
    ....
  27. doi request reprint Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents
    J Ribamar Costa
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    EuroIntervention 8:225-34. 2012
    ....
  28. ncbi request reprint Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries
    J Eduardo Sousa
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Circulation 107:381-3. 2003
    ..We sought to evaluate the angiographic, intravascular ultrasound (IVUS), and clinical outcomes of patients treated with sirolimus-eluting stents 2 years after implantation...
  29. doi request reprint Serial angiography and intravascular ultrasound: results of the SISC Registry (Stents In Small Coronaries)
    Daniel Chamié
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    JACC Cardiovasc Interv 3:191-202. 2010
    ..Sunnyvale, California) against the Multi-Link Pixel (MLP) stent (Guidant Corp., Santa Clara, California) for small vessel percutaneous coronary intervention (PCI)...
  30. ncbi request reprint Angiographic and intravascular ultrasound findings following implantation of the Endeavor zotarolimus-eluting stents in patients from the real-world clinical practice
    Fausto Feres
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    EuroIntervention 5:355-62. 2009
    ..The aim of this study was to investigate the angiographic and intravascular ultrasound (IVUS) findings of the Endeavor zotarolimus-eluting stent (ZES) in patients from a "real-world" clinical practice...
  31. ncbi request reprint Long-term follow up of diabetic patients treated with sirolimus-eluting stents. An angiographic and three-dimensional intravascular ultrasound study
    Vinicius D Vaz
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    J Invasive Cardiol 18:142-6. 2006
    ..The long-term follow up of diabetic patients treated with SES has not been yet evaluated...
  32. ncbi request reprint IMPACT Trial: angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent system
    Alexandre Abizaid
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Catheter Cardiovasc Interv 66:491-5. 2005
    ..Further testing with different drug dosing or delivery rate might improve these results...
  33. doi request reprint Correlation between quantitative angiographic and intravascular ultrasound parameters in patients treated with sirolimus analogous-eluting stents
    Leandro Ignacio Lasave
    Instituto Dante Pazzanese de Cardiologia, Rua Dr Dante Pazzanese, Sao Paulo, Brazil
    Int J Cardiovasc Imaging 25:345-51. 2009
    ..Of note, QCA LL (c = 0.99) correlated best with TLR, even better than percent DS. In the DES era there is a good correlation between QCA measured LL and IVUS IH volume and therefore can be used as a surrogate of DES efficacy...
  34. ncbi request reprint Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial
    Alexandre Abizaid
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Eur Heart J 25:107-12. 2004
    ..007). Conclusion Diabetics treated with SES were associated with a virtual abolition of neointimal proliferation and low event rates at long-term follow-up...
  35. doi request reprint Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry
    Amanda Sousa
    Hospital do Coração Associação do Sanatório Sírio, Sao Paulo, Sao Paulo, Brazil
    J Interv Cardiol 21:307-14. 2008
    ..Recently, cardiologists have treated more complex patients and lesions with drug-eluting stents (DES). However, long-term efficacy and safety of the off-label use of these new devices is yet to be demonstrated...
  36. ncbi request reprint Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry
    J Ribamar Costa
    Hospital do Coração Associação do Sanatório Sírio, Sao Paulo, Brazil
    J Invasive Cardiol 20:404-10. 2008
    ..We sought to compare the very long-term (> 1 year) clinical follow up of octogenarians treated with DES compared to younger individuals...
  37. ncbi request reprint A comparison of rescue and primary percutaneous coronary interventions for acute myocardial infarction: a multicenter registry report of 9,371 patients
    Luiz Alberto Mattos
    Instituto Dante Pazzanese de Cardiologia e Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 82:440-4, 434-9. 2004
    ..To perform a comparative analysis of in-hospital results obtained from AMI patients who underwent rescue or primary PTCA...
  38. ncbi request reprint Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis
    Cesar A Esteves
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Am J Cardiol 98:812-6. 2006
    ....
  39. ncbi request reprint Drug-eluting stents: cost versus clinical benefit
    Pedro A Lemos
    Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands
    Circulation 107:3003-7. 2003
  40. ncbi request reprint Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after intracoronary beta-radiation for the treatment of in-stent restenosis
    Fausto Feres
    Invasive Cardiology Department, Instituto Dante Pazzanese de Cardiologia, Av Dr Dante Pazzanese 500, São Paulo SP 04012 180, Brazil
    J Invasive Cardiol 17:473-7. 2005
    ..Intracoronary beta-radiation for the treatment of ISR was associated with significant luminal deterioration (late catch-up) within the stents between 6 and 12 months due to an important late progression of in-stent intimal hyperplasia...
  41. ncbi request reprint Efficacy and feasibility of helixcision for debulking neointimal hyperplasia for in-stent restenosis
    Mamoo Nakamura
    Stanford University Medical Center, Stanford, California 94305, USA
    Catheter Cardiovasc Interv 57:460-6. 2002
    ..The long-term outcomes appeared to be favorable, considering the relatively diffuse lesion morphology...
  42. ncbi request reprint Fate of side branches after coronary arterial sirolimus-eluting stent implantation
    Kengo Tanabe
    Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 90:937-41. 2002
    ..Thus, the fate of side branches after SES implantation is favorable and at least as good as after UMS implantation...
  43. ncbi request reprint What is "the matter" with restenosis in 2002?
    J Eduardo Sousa
    Circulation 105:2932-3. 2002
  44. ncbi request reprint A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    N Engl J Med 346:1773-80. 2002
    ..Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle cells, we compared a sirolimus-eluting stent with a standard uncoated stent in patients with angina pectoris...
  45. ncbi request reprint Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial
    Jean Fajadet
    Clinique Pasteur, 45, Avenue du Lombez, 31300 Toulouse, France
    Circulation 111:1040-4. 2005
    ..This analysis examined whether these beneficial effects persist over the longer term...
  46. doi request reprint Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents
    Eugenia Nikolsky
    Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Catheter Cardiovasc Interv 71:896-906. 2008
    ..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
  47. ncbi request reprint Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients
    Jiro Aoki
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 46:1670-6. 2005
    ..This study sought to evaluate the long-term arterial response after sirolimus-eluting stent implantation...
  48. ncbi request reprint Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 44:1363-7. 2004
    ..We sought to demonstrate the safety and performance of the actinomycin D-coated Multilink-Tetra stent(Guidant Corp., Santa Clara, California) in the treatment of patients with single de novo native coronary lesions...
  49. ncbi request reprint Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry
    Philip Urban
    La Tour Hospital, Geneva, Switzerland
    Circulation 113:1434-41. 2006
    ..The e-Cypher registry monitored the safety and efficacy of SES currently implanted worldwide in daily practice...
  50. ncbi request reprint [Comparative assessment of the prognostic value of four biochemical markers of myocardial damage after percutaneous coronary stenting]
    Marinella Centemero
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP
    Arq Bras Cardiol 83:53-8. 2004
  51. ncbi request reprint Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions
    Ricardo A Costa
    The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 98:443-6. 2006
    ..14 +/- 0.45 vs 0.40 +/- 0.41 mm, p = 0.004). In-stent restenosis was 3.9% in the Biolimus stent group versus 7.7% in the control group (p = 0.40). There was no exaggerated hyperplasia at the proximal and/or distal edge of the stent...
  52. ncbi request reprint Initial experience with the novel 6 Fr-compatible system for debulking de novo coronary arterial lesions
    Fumiaki Ikeno
    Stanford University Medical Center, Stanford, California, USA
    Catheter Cardiovasc Interv 62:308-17. 2004
    ..Quantitative angiographic and IVUS analysis indicate that this system can effectively debulk plaque from selected noncalcified atherosclerotic lesions and thus may represent an alternative treatment strategy for coronary artery disease...
  53. ncbi request reprint [Relationship between plasma C-reactive protein level and neointimal hyperplasia volume in patients with zotarolimus-eluting stents. Volumetric analysis by three-dimensional intracoronary ultrasound]
    Leandro I Lasave
    Servicio de Hemodinámica y Cardiología Intervencionista, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brasil
    Rev Esp Cardiol 60:923-31. 2007
    ..The objective of this study was to investigate the relationship between the basal CRP level and the neointimal hyperplasia volume measured by intracoronary ultrasound 4 months after implantation of a zotarolimus-eluting stent...
  54. ncbi request reprint Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions
    Muzaffer Degertekin
    Department of Cardiology, Erasmus Medical Center, Thoraxcenter, Bd 48, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur Heart J 25:32-8. 2004
    ..The aim of this study is to compare the efficacy of sirolimus-eluting stents (SES) on neointimal growth and vessel remodelling for in-stent restenosis versus de novo coronary artery lesions using serial intravascular ultrasound (IVUS)...
  55. ncbi request reprint Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial
    Marco A Costa
    University of Florida, Shands Jacksonville, Cardiovascular Center, Jacksonville, FL 32209, USA
    Am Heart J 153:296.e1-7. 2007
    ..The objective of our study was to investigate the correlation between angiography, intravascular ultrasound (IVUS), and fractional flow reserve (FFR) in patients with moderate stenoses in small (<2.8 mm) coronary arteries...
  56. ncbi request reprint [Guidelines for the indications and use of percutaneous interventions and intracoronary stent in clinical practice]
    Jorge Ilha Guimaraes
    Arq Bras Cardiol 80:1-14. 2003
  57. ncbi request reprint Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial
    Patrick W Serruys
    Interventional Cardiology Department, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 46:575-81. 2005
    ..The long-term (five-year) comparative results of treatment of multivessel coronary artery disease with stenting or coronary artery bypass grafting (CABG) is at present unknown...
  58. ncbi request reprint Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial
    Jiro Aoki
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur Heart J 26:1488-93. 2005
    ..To compare coronary stent implantation and bypass surgery for multivessel coronary disease in patients with renal insufficiency...
  59. doi request reprint The revascular active percutaneous interventional device for coronary total occlusions study
    Daniel Chamié
    Interventional Cardiology Department, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brasil
    Catheter Cardiovasc Interv 72:156-63. 2008
    ..We sought to evaluate the efficacy and safety of the novel RVT CTO Guidewire Device (RVT-GDW, ReVascular Therapeutics, Sunnyvale, CA) in this complex scenario...